世界のプソイドエフェドリン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pseudoephedrine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4852 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、プソイドエフェドリンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品有効成分、調製）、用途別市場規模（副鼻腔炎、うっ血性鼻炎、気管支喘息、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・プソイドエフェドリンの市場動向 ・企業の競争状況、市場シェア ・プソイドエフェドリンの種類別市場規模（医薬品有効成分、調製） ・プソイドエフェドリンの用途別市場規模（副鼻腔炎、うっ血性鼻炎、気管支喘息、その他） ・プソイドエフェドリンの北米市場規模2016-2027（アメリカ、カナダ） ・プソイドエフェドリンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・プソイドエフェドリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・プソイドエフェドリンの中南米市場規模2016-2027（メキシコ、ブラジル） ・プソイドエフェドリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer (Wyeth)、Endo International、Sanofi、Hanmi、Merck、Cypress Pharma、Johnson & Johnson、Kroger Company、CVS Caremark、Ratiopharm (Teva)、UCB, Inc、Pacific Pharmal、Sun Pharmaceutical、Apotec、Zhuhai Tianda Pharma、Sichuan Shenghe Pharmaceutical） ・結論

Market Analysis and Insights: Global Pseudoephedrine Market
The global Pseudoephedrine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pseudoephedrine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pseudoephedrine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pseudoephedrine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pseudoephedrine market.

Global Pseudoephedrine Scope and Market Size
Pseudoephedrine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pseudoephedrine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Active Pharmaceutical Ingredients
Preparation

Segment by Application
Sinusitis
Congestive Rhinitis
Bronchial Asthma
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer (Wyeth)
Endo International
Sanofi
Hanmi
Merck
Cypress Pharma
Johnson & Johnson
Kroger Company
CVS Caremark
Ratiopharm (Teva)
UCB, Inc
Pacific Pharmal
Sun Pharmaceutical
Apotec

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudoephedrine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Pseudoephedrine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sinusitis
1.3.3 Congestive Rhinitis
1.3.4 Bronchial Asthma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pseudoephedrine Market Perspective (2016-2027)
2.2 Pseudoephedrine Growth Trends by Regions
2.2.1 Pseudoephedrine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pseudoephedrine Historic Market Share by Regions (2016-2021)
2.2.3 Pseudoephedrine Forecasted Market Size by Regions (2022-2027)
2.3 Pseudoephedrine Industry Dynamic
2.3.1 Pseudoephedrine Market Trends
2.3.2 Pseudoephedrine Market Drivers
2.3.3 Pseudoephedrine Market Challenges
2.3.4 Pseudoephedrine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pseudoephedrine Players by Revenue
3.1.1 Global Top Pseudoephedrine Players by Revenue (2016-2021)
3.1.2 Global Pseudoephedrine Revenue Market Share by Players (2016-2021)
3.2 Global Pseudoephedrine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pseudoephedrine Revenue
3.4 Global Pseudoephedrine Market Concentration Ratio
3.4.1 Global Pseudoephedrine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudoephedrine Revenue in 2020
3.5 Pseudoephedrine Key Players Head office and Area Served
3.6 Key Players Pseudoephedrine Product Solution and Service
3.7 Date of Enter into Pseudoephedrine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pseudoephedrine Breakdown Data by Type
4.1 Global Pseudoephedrine Historic Market Size by Type (2016-2021)
4.2 Global Pseudoephedrine Forecasted Market Size by Type (2022-2027)

5 Pseudoephedrine Breakdown Data by Application
5.1 Global Pseudoephedrine Historic Market Size by Application (2016-2021)
5.2 Global Pseudoephedrine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pseudoephedrine Market Size (2016-2027)
6.2 North America Pseudoephedrine Market Size by Type
6.2.1 North America Pseudoephedrine Market Size by Type (2016-2021)
6.2.2 North America Pseudoephedrine Market Size by Type (2022-2027)
6.2.3 North America Pseudoephedrine Market Size by Type (2016-2027)
6.3 North America Pseudoephedrine Market Size by Application
6.3.1 North America Pseudoephedrine Market Size by Application (2016-2021)
6.3.2 North America Pseudoephedrine Market Size by Application (2022-2027)
6.3.3 North America Pseudoephedrine Market Size by Application (2016-2027)
6.4 North America Pseudoephedrine Market Size by Country
6.4.1 North America Pseudoephedrine Market Size by Country (2016-2021)
6.4.2 North America Pseudoephedrine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pseudoephedrine Market Size (2016-2027)
7.2 Europe Pseudoephedrine Market Size by Type
7.2.1 Europe Pseudoephedrine Market Size by Type (2016-2021)
7.2.2 Europe Pseudoephedrine Market Size by Type (2022-2027)
7.2.3 Europe Pseudoephedrine Market Size by Type (2016-2027)
7.3 Europe Pseudoephedrine Market Size by Application
7.3.1 Europe Pseudoephedrine Market Size by Application (2016-2021)
7.3.2 Europe Pseudoephedrine Market Size by Application (2022-2027)
7.3.3 Europe Pseudoephedrine Market Size by Application (2016-2027)
7.4 Europe Pseudoephedrine Market Size by Country
7.4.1 Europe Pseudoephedrine Market Size by Country (2016-2021)
7.4.2 Europe Pseudoephedrine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pseudoephedrine Market Size (2016-2027)
8.2 Asia-Pacific Pseudoephedrine Market Size by Type
8.2.1 Asia-Pacific Pseudoephedrine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pseudoephedrine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pseudoephedrine Market Size by Type (2016-2027)
8.3 Asia-Pacific Pseudoephedrine Market Size by Application
8.3.1 Asia-Pacific Pseudoephedrine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pseudoephedrine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pseudoephedrine Market Size by Application (2016-2027)
8.4 Asia-Pacific Pseudoephedrine Market Size by Region
8.4.1 Asia-Pacific Pseudoephedrine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pseudoephedrine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pseudoephedrine Market Size (2016-2027)
9.2 Latin America Pseudoephedrine Market Size by Type
9.2.1 Latin America Pseudoephedrine Market Size by Type (2016-2021)
9.2.2 Latin America Pseudoephedrine Market Size by Type (2022-2027)
9.2.3 Latin America Pseudoephedrine Market Size by Type (2016-2027)
9.3 Latin America Pseudoephedrine Market Size by Application
9.3.1 Latin America Pseudoephedrine Market Size by Application (2016-2021)
9.3.2 Latin America Pseudoephedrine Market Size by Application (2022-2027)
9.3.3 Latin America Pseudoephedrine Market Size by Application (2016-2027)
9.4 Latin America Pseudoephedrine Market Size by Country
9.4.1 Latin America Pseudoephedrine Market Size by Country (2016-2021)
9.4.2 Latin America Pseudoephedrine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pseudoephedrine Market Size (2016-2027)
10.2 Middle East & Africa Pseudoephedrine Market Size by Type
10.2.1 Middle East & Africa Pseudoephedrine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pseudoephedrine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pseudoephedrine Market Size by Type (2016-2027)
10.3 Middle East & Africa Pseudoephedrine Market Size by Application
10.3.1 Middle East & Africa Pseudoephedrine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pseudoephedrine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pseudoephedrine Market Size by Application (2016-2027)
10.4 Middle East & Africa Pseudoephedrine Market Size by Country
10.4.1 Middle East & Africa Pseudoephedrine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pseudoephedrine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer (Wyeth)
11.1.1 Pfizer (Wyeth) Company Details
11.1.2 Pfizer (Wyeth) Business Overview
11.1.3 Pfizer (Wyeth) Pseudoephedrine Introduction
11.1.4 Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2016-2021)
11.1.5 Pfizer (Wyeth) Recent Development
11.2 Endo International
11.2.1 Endo International Company Details
11.2.2 Endo International Business Overview
11.2.3 Endo International Pseudoephedrine Introduction
11.2.4 Endo International Revenue in Pseudoephedrine Business (2016-2021)
11.2.5 Endo International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pseudoephedrine Introduction
11.3.4 Sanofi Revenue in Pseudoephedrine Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Hanmi
11.4.1 Hanmi Company Details
11.4.2 Hanmi Business Overview
11.4.3 Hanmi Pseudoephedrine Introduction
11.4.4 Hanmi Revenue in Pseudoephedrine Business (2016-2021)
11.4.5 Hanmi Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Pseudoephedrine Introduction
11.5.4 Merck Revenue in Pseudoephedrine Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Cypress Pharma
11.6.1 Cypress Pharma Company Details
11.6.2 Cypress Pharma Business Overview
11.6.3 Cypress Pharma Pseudoephedrine Introduction
11.6.4 Cypress Pharma Revenue in Pseudoephedrine Business (2016-2021)
11.6.5 Cypress Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Pseudoephedrine Introduction
11.7.4 Johnson & Johnson Revenue in Pseudoephedrine Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Kroger Company
11.8.1 Kroger Company Company Details
11.8.2 Kroger Company Business Overview
11.8.3 Kroger Company Pseudoephedrine Introduction
11.8.4 Kroger Company Revenue in Pseudoephedrine Business (2016-2021)
11.8.5 Kroger Company Recent Development
11.9 CVS Caremark
11.9.1 CVS Caremark Company Details
11.9.2 CVS Caremark Business Overview
11.9.3 CVS Caremark Pseudoephedrine Introduction
11.9.4 CVS Caremark Revenue in Pseudoephedrine Business (2016-2021)
11.9.5 CVS Caremark Recent Development
11.10 Ratiopharm (Teva)
11.10.1 Ratiopharm (Teva) Company Details
11.10.2 Ratiopharm (Teva) Business Overview
11.10.3 Ratiopharm (Teva) Pseudoephedrine Introduction
11.10.4 Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2016-2021)
11.10.5 Ratiopharm (Teva) Recent Development
11.11 UCB, Inc
11.11.1 UCB, Inc Company Details
11.11.2 UCB, Inc Business Overview
11.11.3 UCB, Inc Pseudoephedrine Introduction
11.11.4 UCB, Inc Revenue in Pseudoephedrine Business (2016-2021)
11.11.5 UCB, Inc Recent Development
11.12 Pacific Pharmal
11.12.1 Pacific Pharmal Company Details
11.12.2 Pacific Pharmal Business Overview
11.12.3 Pacific Pharmal Pseudoephedrine Introduction
11.12.4 Pacific Pharmal Revenue in Pseudoephedrine Business (2016-2021)
11.12.5 Pacific Pharmal Recent Development
11.13 Sun Pharmaceutical
11.13.1 Sun Pharmaceutical Company Details
11.13.2 Sun Pharmaceutical Business Overview
11.13.3 Sun Pharmaceutical Pseudoephedrine Introduction
11.13.4 Sun Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021)
11.13.5 Sun Pharmaceutical Recent Development
11.14 Apotec
11.14.1 Apotec Company Details
11.14.2 Apotec Business Overview
11.14.3 Apotec Pseudoephedrine Introduction
11.14.4 Apotec Revenue in Pseudoephedrine Business (2016-2021)
11.14.5 Apotec Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Details
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Pseudoephedrine Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2016-2021)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Details
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Pseudoephedrine Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pseudoephedrine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Active Pharmaceutical Ingredients
Table 3. Key Players of Preparation
Table 4. Global Pseudoephedrine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pseudoephedrine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pseudoephedrine Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pseudoephedrine Market Share by Regions (2016-2021)
Table 8. Global Pseudoephedrine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pseudoephedrine Market Share by Regions (2022-2027)
Table 10. Pseudoephedrine Market Trends
Table 11. Pseudoephedrine Market Drivers
Table 12. Pseudoephedrine Market Challenges
Table 13. Pseudoephedrine Market Restraints
Table 14. Global Pseudoephedrine Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pseudoephedrine Market Share by Players (2016-2021)
Table 16. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudoephedrine as of 2020)
Table 17. Ranking of Global Top Pseudoephedrine Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pseudoephedrine Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pseudoephedrine Product Solution and Service
Table 21. Date of Enter into Pseudoephedrine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pseudoephedrine Revenue Market Share by Type (2016-2021)
Table 25. Global Pseudoephedrine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pseudoephedrine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pseudoephedrine Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pseudoephedrine Revenue Market Share by Application (2016-2021)
Table 29. Global Pseudoephedrine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pseudoephedrine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pseudoephedrine Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pseudoephedrine Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pseudoephedrine Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pseudoephedrine Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pseudoephedrine Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pseudoephedrine Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pseudoephedrine Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pseudoephedrine Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pseudoephedrine Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pseudoephedrine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pseudoephedrine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pseudoephedrine Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pseudoephedrine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pseudoephedrine Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pseudoephedrine Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pseudoephedrine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pseudoephedrine Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pseudoephedrine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pseudoephedrine Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pseudoephedrine Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pseudoephedrine Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pseudoephedrine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pseudoephedrine Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pseudoephedrine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pseudoephedrine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pseudoephedrine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer (Wyeth) Company Details
Table 62. Pfizer (Wyeth) Business Overview
Table 63. Pfizer (Wyeth) Pseudoephedrine Product
Table 64. Pfizer (Wyeth) Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 65. Pfizer (Wyeth) Recent Development
Table 66. Endo International Company Details
Table 67. Endo International Business Overview
Table 68. Endo International Pseudoephedrine Product
Table 69. Endo International Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 70. Endo International Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Pseudoephedrine Product
Table 74. Sanofi Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Hanmi Company Details
Table 77. Hanmi Business Overview
Table 78. Hanmi Pseudoephedrine Product
Table 79. Hanmi Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 80. Hanmi Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Pseudoephedrine Product
Table 84. Merck Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Cypress Pharma Company Details
Table 87. Cypress Pharma Business Overview
Table 88. Cypress Pharma Pseudoephedrine Product
Table 89. Cypress Pharma Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 90. Cypress Pharma Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Pseudoephedrine Product
Table 94. Johnson & Johnson Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Kroger Company Company Details
Table 97. Kroger Company Business Overview
Table 98. Kroger Company Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 99. Kroger Company Recent Development
Table 100. CVS Caremark Company Details
Table 101. CVS Caremark Business Overview
Table 102. CVS Caremark Pseudoephedrine Product
Table 103. CVS Caremark Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 104. CVS Caremark Recent Development
Table 105. Ratiopharm (Teva) Company Details
Table 106. Ratiopharm (Teva) Business Overview
Table 107. Ratiopharm (Teva) Pseudoephedrine Product
Table 108. Ratiopharm (Teva) Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 109. Ratiopharm (Teva) Recent Development
Table 110. UCB, Inc Company Details
Table 111. UCB, Inc Business Overview
Table 112. UCB, Inc Pseudoephedrine Product
Table 113. UCB, Inc Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 114. UCB, Inc Recent Development
Table 115. Pacific Pharmal Company Details
Table 116. Pacific Pharmal Business Overview
Table 117. Pacific Pharmal Pseudoephedrine Product
Table 118. Pacific Pharmal Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 119. Pacific Pharmal Recent Development
Table 120. Sun Pharmaceutical Company Details
Table 121. Sun Pharmaceutical Business Overview
Table 122. Sun Pharmaceutical Pseudoephedrine Product
Table 123. Sun Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 124. Sun Pharmaceutical Recent Development
Table 125. Apotec Company Details
Table 126. Apotec Business Overview
Table 127. Apotec Pseudoephedrine Product
Table 128. Apotec Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 129. Apotec Recent Development
Table 130. Zhuhai Tianda Pharma Company Details
Table 131. Zhuhai Tianda Pharma Business Overview
Table 132. Zhuhai Tianda Pharma Pseudoephedrine Product
Table 133. Zhuhai Tianda Pharma Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 134. Zhuhai Tianda Pharma Recent Development
Table 135. Sichuan Shenghe Pharmaceutical Company Details
Table 136. Sichuan Shenghe Pharmaceutical Business Overview
Table 137. Sichuan Shenghe Pharmaceutical Pseudoephedrine Product
Table 138. Sichuan Shenghe Pharmaceutical Revenue in Pseudoephedrine Business (2016-2021) & (US$ Million)
Table 139. Sichuan Shenghe Pharmaceutical Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudoephedrine Market Share by Type: 2020 VS 2027
Figure 2. Active Pharmaceutical Ingredients Features
Figure 3. Preparation Features
Figure 4. Global Pseudoephedrine Market Share by Application: 2020 VS 2027
Figure 5. Sinusitis Case Studies
Figure 6. Congestive Rhinitis Case Studies
Figure 7. Bronchial Asthma Case Studies
Figure 8. Other Case Studies
Figure 9. Pseudoephedrine Report Years Considered
Figure 10. Global Pseudoephedrine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pseudoephedrine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pseudoephedrine Market Share by Regions: 2020 VS 2027
Figure 13. Global Pseudoephedrine Market Share by Regions (2022-2027)
Figure 14. Global Pseudoephedrine Market Share by Players in 2020
Figure 15. Global Top Pseudoephedrine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudoephedrine as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pseudoephedrine Revenue in 2020
Figure 17. Global Pseudoephedrine Revenue Market Share by Type (2016-2021)
Figure 18. Global Pseudoephedrine Revenue Market Share by Type (2022-2027)
Figure 19. North America Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pseudoephedrine Market Share by Type (2016-2027)
Figure 21. North America Pseudoephedrine Market Share by Application (2016-2027)
Figure 22. North America Pseudoephedrine Market Share by Country (2016-2027)
Figure 23. United States Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pseudoephedrine Market Share by Type (2016-2027)
Figure 27. Europe Pseudoephedrine Market Share by Application (2016-2027)
Figure 28. Europe Pseudoephedrine Market Share by Country (2016-2027)
Figure 29. Germany Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pseudoephedrine Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pseudoephedrine Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pseudoephedrine Market Share by Region (2016-2027)
Figure 39. China Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pseudoephedrine Market Share by Type (2016-2027)
Figure 47. Latin America Pseudoephedrine Market Share by Application (2016-2027)
Figure 48. Latin America Pseudoephedrine Market Share by Country (2016-2027)
Figure 49. Mexico Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pseudoephedrine Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pseudoephedrine Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pseudoephedrine Market Share by Country (2016-2027)
Figure 55. Turkey Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pseudoephedrine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer (Wyeth) Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 59. Endo International Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 61. Hanmi Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 63. Cypress Pharma Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 65. Kroger Company Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 66. CVS Caremark Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 67. Ratiopharm (Teva) Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 68. UCB, Inc Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 69. Pacific Pharmal Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 70. Sun Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 71. Apotec Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 72. Zhuhai Tianda Pharma Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 73. Sichuan Shenghe Pharmaceutical Revenue Growth Rate in Pseudoephedrine Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---